Imux ticker
Web1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 332 2559811 Email: [email protected] WebOct 10, 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology...
Imux ticker
Did you know?
http://openinsider.com/IMUX WebApr 6, 2024 · Immunic, Inc. is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. It is engaged in the clinical development of three orally administered, small molecule programs to address the unmet needs of patients.
WebInsider trades for Immunic, Inc. (IMUX). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. ... Ticker Insider Name Title Trade Type Price Qty Owned ΔOwn Value 1d 1w 1m 6m; M: 2024-12-15 16:06:28. 2024-12-13. IMUX: Neermann Joerg: Dir: P - Purchase: $1.25 +82,000: 100,000 +456% WebImmunic, Inc (NASDAQ: IMUX) reported data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset, vidofludimus calcium (IMU-838), in patients with moderate … Find the latest Immunic, Inc. (IMUX) stock discussion in Yahoo Finance's forum. … Discover historical prices for IMUX stock on Yahoo Finance. View daily, weekly or … Find out all the key statistics for Immunic, Inc. (IMUX), including valuation … Find out the direct holders, institutional holders and mutual fund holders for … See Immunic, Inc. (IMUX) Environment, Social and Governance Ratings to help … See Immunic, Inc. (IMUX) stock analyst estimates, including earnings and … Immunic (IMUX) reports positive results from the maintenance phase of the … Get the detailed quarterly/annual income statement for Immunic, Inc. (IMUX). Find … Find the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital … Find the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital …
WebDec-10-21 06:26AM. Insiders who bought Immunic, Inc. (NASDAQ:IMUX) stock in the last 12 months recover some losses, but still down US$82k. Simply Wall St. Dec-09-21 04:01PM. Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer. WebApr 12, 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol …
Web23 hours ago · Storage news ticker – April 14. Managed infrastructure solutions provider 11:11 Systems announced GA of the fully-managed 11:11 Managed SteelDome in partnership with SteelDome Cyber. This provides secure, scalable and cost-efficient storage of customers’ unstructured, on-premises data and uses SteelDome’s InfiniVault storage …
WebPROFILE ( IMUX) Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic … blooms cherriesWebJan 3, 2024 · Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory … blooms citiWebManagement Effectiveness Profitability Currency in USD. Quote data delayed by at least 15 minutes. Immunic, Inc. 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA … free.download zoomWebImmunic AG was founded in 2016 with headquarters in Planegg-Martinsried, Germany. Since April 2024, the company has been operating under the name Immunic, Inc. with its … bloom schools photography discount codeWebMar 31, 2024 · Open an account. Provide your personal information and sign up. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account. Search for the stock name – IMUX. Search for the stock by name or ticker symbol. Buy the stock. Place your order. free download zoom on laptopWebFeb 24, 2024 · Ticker: IMUX CIK: 1280776 Form Type: 10-K Annual Report Accession Number: 0001280776-22-000006 Submitted to the SEC: Thu Feb 24 2024 7:07:01 AM EST Accepted by the SEC: Thu Feb 24 2024 Period: Friday, December 31, 2024 Industry: Pharmaceutical Preparations External Resources: Stock Quote free download zoom appWebThe best-performing ETF in the past 12 months with IMUX as a holding is the Global X Russell 2000 Covered Call ETF (RYLD), with a return of 2.17%. ETF s with the most IMUX … free download zoom camera